David Soleimani-Meigooni, MD, is a neurologist at the UCSF Edward and Pearl Fein Memory and Aging Center, where he specializes in the diagnosis and care of patients with cognitive symptoms caused by neurodegenerative diseases, including Alzheimer’s disease.
Dr. Soleimani-Meigooni’s research focuses on advancing precision medicine approaches for diagnosing Alzheimer’s disease and other neurodegenerative disorders. Specifically, his work examines the use of positron emission tomography (PET) imaging to study the accumulation of amyloid-beta and tau proteins, which play a key role in these diseases. He also collaborates with researchers to develop PET imaging techniques for measuring the accumulation of four-repeat tau in certain types of frontotemporal dementia and changes in synaptic density, astrocytes, microglia, and myelin that can accompany neurodegeneration in the brain. His research has been supported by the Alzheimer's Association and the National Institutes of Health (NIH).
Dr. Soleimani-Meigooni earned his medical degree from UCSF. He completed his neurology residency at Washington University School of Medicine in St. Louis, where he served as chief resident for education and quality improvement. He then returned to UCSF for a fellowship in cognitive and behavioral neurology and is currently an assistant professor at the Fein Memory and Aging Center.
Passionate about improving the lives of patients with neurodegenerative diseases, Dr. Soleimani-Meigooni combines compassionate patient care with cutting-edge research. His work aims to refine diagnostic tools and pave the way for more personalized treatment strategies for individuals affected by conditions such as Alzheimer’s disease.